Clinical Trial Report

Quality of Life in Japanese Patients with Dysmenorrhea Treated with Ethinylestradiol 20 μg/Drospirenone 3 mg in a Real-World Setting: An Observational Study

Momoeda M, Akiyama S, Tanaka K, Suzukamo Y

International Journal of Women's Health 2020, 12:327-338

Published Date: 4 May 2020